NCT06134375 2026-03-12
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Dartmouth-Hitchcock Medical Center
Phase 1/2 Recruiting
Clinical Trials
3 trialsNCT00195091 2025-05-16
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT00674557 2013-07-10
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Terminated